Purchases and Sales Made in Q2 2024 in Fennec Pharmaceuticals Inc. (FENC)
This table provides information about the institutional ownership of Fennec Pharmaceuticals Inc. (FENC) during Q2 2024. The information is specifically focused on institutions that hold shares of FENNEC PHARMACEUTICALS INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 07, 2024
Q2 2024
|
Cibc World Market Inc.
Toronto, A6 |
SELL
|
- |
-13.2K- 18.81% |
$79.3K - $145K
|
56.9K
$498K
|
|
|
Aug 14, 2024
Q2 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-16K- 47.46% |
$96.3K - $176K
|
17.7K
$155K
|
|
|
Aug 14, 2024
Q2 2024
|
Gendell Jeffrey L
Greenwich, CT |
SELL
|
- |
-19.1K- 6.32% |
$115K - $210K
|
283K
$2.48M
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-22.4K- 75.46% |
$135K - $246K
|
7.27K
$63.6K
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-23K- 53.28% |
$138K - $252K
|
20.1K
$176K
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-244K- 70.53% |
$1.47M - $2.68M
|
102K
$893K
|